IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 364 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $483,272 | +14.7% | 10,140 | +4.4% | 0.16% | +9.5% |
Q1 2024 | $421,189 | -2.3% | 9,716 | +14.1% | 0.15% | -14.0% |
Q4 2023 | $430,976 | +21.4% | 8,519 | +8.9% | 0.17% | +7.5% |
Q3 2023 | $354,942 | +31.2% | 7,825 | +18.7% | 0.16% | +35.6% |
Q2 2023 | $270,511 | – | 6,593 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |